George Poste
Director · Caris Life Sciences, Inc.
- 2024
- Jun 2, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies George Poste files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David Baxley Spetzler - $14.84M in CAI purchases and sales in the last 12 months
- Brian J. Brille - $12.13M in CAI purchases and sales in the last 12 months
- Dana Aftab - $7.70M in EXEL purchases and sales in the last 12 months
- Patrick J. Haley - $7.60M in EXEL purchases and sales in the last 12 months
- Julie Smith - $4.69M in EXEL purchases and sales in the last 12 months
- Jack L. Wyszomierski - $4.58M in EXEL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is George Poste?
George Poste is a corporate insider, tracked as Director of Caris Life Sciences, Inc. (CAI). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did George Poste last file a Form 4?
The most recent primary Form 4 on record is dated 2 June 2026, one of 7 filings going back to 2024.
Has George Poste been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($4.71M) across all tracked filings.
